Position in INBX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$246,350
New position
Shares Held
2,600
first reported quarter
Ownership
0.018%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#115
of 161 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HARVEST MANAGEMENT LLC holds $25,872,051 across 9 Biotechnology names. INBX ranks #7 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
170,000 | $12,010,500 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
79,000 | $10,485,670 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
7,221 | $1,352,348 | |
| 4 | CYTK |
Cytokinetics Inc
|
12,400 | $1,056,356 | |
| 5 | ABVX |
Abivax S.A.
|
2,800 | $373,128 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
1,100 | $347,699 | |
| 7 | INBX |
Inhibrx Biosciences, Inc.
This page
|
2,600 | $246,350 | |
| 8 | 150,000 | $0 |
All Filings in INBX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $246,350 | 2,600 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||